Introduction: AF ablation improves symptoms and systolic function in patients with comorbid persistent AF (PeAF) and idiopathic cardiomyopathy (IDCM). We investigated if diffuse ventricular fibrosis, as measured by cardiac MRI, improves in concert with LVEF following catheter ablation. Methods: Patients with IDCM (LVEF≤45%) and PeAF undergoing AF ablation and no contraindication to cardiac MRI (CMR) were prospectively enrolled and implanted with loop recorders. All patients underwent CMR with native ventricular T1 mapping, a histologically validated index of diffuse ventricular fibrosis, and BNP, prior to and at 6 months post ablation. Results: 18 patients were enrolled (age 59 ± 13, 92% male, mean AF duration 12 ± 5.4 months, NYHA class 2.5 ± 0.5, mean heart rate 81 ± 12bpm and LA size: 34 ± 4.0 cm2). All patients underwent catheter ablation (PVI and posterior LA isolation) and were in SR at 6-month follow-up (AF burden <5% in 94% patients). There was a significant improvement in LVEF from baseline (33 ± 8.0% vs 47 ± 11%, p < 0.001) and a reduction in BNP (-351 ± 213 vs 109 ± 100 ng/L, p < 0.001) and NYHA class (2.5 ± 0.5 vs 1.3 ± 0.6, p < 0.001). This was associated with reduction in average native T1 time from baseline to 6 months (1285 ± 120ms vs 1199 ± 73ms, p = 0.014). Conclusion: Recovery of LVEF in patients with PeAF and IDCM undergoing AF ablation is associated with a shortening of native T1 times consistent with regression of ventricular fibrosis. The restoration of SR with AF ablation promotes reverse ventricular structural remodelling in patients with IDCM and PeAF.
Read full abstract